Across TCGA pan-cancer cohorts, LINC00456 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC00456’s most consistent transcriptional readouts.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where LINC00456 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00456 is over-expressed in tumor.
BLCA and STAD are the cancer types where LINC00456 tumor–normal differential expression is most reproducible.